Felodipine
- Product NDC
- 69367-264
- 11-digit product format
- 693670264
- Labeler code
- 69367
- Product ID
- 69367-264_51791555-1064-4991-b58c-3a37ce596d60
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Felodipine
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Westminster Pharmaceuticals, LLC
- Application
- ANDA210847
- Marketing category
- ANDA
- Marketing start
- 2023-03-31
- Substance
- FELODIPINE
- Active strength
- 2.5 mg/1
- Pharmacologic classes
- Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Felodipine
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| FELODIPINE | 2.5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | OL961R6O2C |
| Rxcui | 402695, 402696, 402698 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 69367-264-01 | Felodipine | 100 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 100 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 69367-264 | FELODIPINE TABLET, EXTENDED RELEASE FELOPDIPINE (FELODIPINE) TABLET, EXTENDED RELEASE [WESTMINSTER PHARMACEUTICALS, LLC] | 1 | Current NDC, 1 package rows | 20230414_a6560584-e39f-47b3-84db-95da1f90fd40.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 69367-264-01 | 69367026401 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (69367-264-01) | 2023-03-31 | No | No | Current |